Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Pharmaceutical Sales by Year
Pharmaceutical Sales — Eastern Europe / Middle East / Africa ($M) ($M)
Merck Pharmaceutical Sales: $1,598M in FY2025, up 6.9% from a year earlier.
Where the FY2025 figure comes from
“|| Eastern Europe/Middle East/Africa | 413 | 408 | 821 | 435 | 451 | 886 | 365 | 348 | 1,598 | -10 | -7”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 8-K Supplemental Table 3c / 3b (Pharmaceutical Geographic Sales).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmaceutical Sales — Eastern Europe / Middle East / Africa ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,598 | +6.9% | Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗ |
| FY2024 | Dec 31, 2024 | 1,495 | +10.7% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | 1,351 | -8.0% | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2022 | Dec 31, 2022 | 1,469 | +11.7% | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 1,315 | +9.7% | Form 8-K (tm235007d1_ex99-1.htm, filed 2023-02-02) ↗ |
| FY2020 | Dec 31, 2020 | 1,199 | -24.0% | Form 8-K (tm2131077d1_ex99-1.htm, filed 2021-10-28) ↗ |
| FY2019 | Dec 31, 2019 | 1,577 | – | Form 8-K (tm2032785d1_ex99-1.htm, filed 2020-10-27) ↗ |
Breakdown
What makes up pharmaceutical Sales
Cite this data
StockData. (2026). Merck Pharmaceutical Sales ($M), annual FY2019–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/pharma-geo-eemea
See every metric in the Merck KPI table. Data updated Oct 26, 2026.